<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Liver transplantation: Preanesthetic consultation and preparations</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Liver transplantation: Preanesthetic consultation and preparations</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Liver transplantation: Preanesthetic consultation and preparations</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gebhard Wagener, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael F O'Connor, MD, FCCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3768485587"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>This topic will discuss preanesthetic consultation and preparations for patients undergoing liver transplantation.</p><p>Anesthetic management during the intraoperative and early postoperative periods is discussed separately. (See  <a class="medical medical_review" href="/d/html/94585.html" rel="external">"Liver transplantation: Anesthetic management"</a>.)</p><p>Patient selection, evaluation, and pre- and postoperative medical management of liver transplant recipients are discussed in separate topics. (See  <a class="medical medical_review" href="/d/html/4585.html" rel="external">"Liver transplantation in adults: Patient selection and pretransplantation evaluation"</a> and  <a class="medical medical_review" href="/d/html/4589.html" rel="external">"Liver transplantation in adults: Long-term management of transplant recipients"</a>.)</p><p>Donor selection after brain death and living donor liver transplantation are also addressed in separate topics. (See  <a class="medical medical_review" href="/d/html/4592.html" rel="external">"Liver transplantation in adults: Deceased donor evaluation and selection"</a> and  <a class="medical medical_review" href="/d/html/4590.html" rel="external">"Living donor liver transplantation in adults"</a>.)</p><p class="headingAnchor" id="H218167897"><span class="h1">PREANESTHETIC CONSULTATION</span></p><p class="headingAnchor" id="H1410666909"><span class="h2">Indications and timing for preanesthetic consultation</span><span class="headingEndMark"> — </span>Transplant recipients may be assessed by an anesthesiology consultant at the time of listing for transplant, especially for planned living donor liver transplantation. However, in some liver transplantation centers, potential recipients are not seen by the anesthesiology team prior to the immediate preoperative period. Patients with high Model for End-stage Liver Disease (MELD) scores and patients admitted to the intensive care unit prior to transplantation are evaluated by the transplant anesthesiology team as early as possible to assess perioperative risk and participate in ensuring optimal clinical status before transplantation. (See  <a class="medical medical_review" href="/d/html/4585.html" rel="external">"Liver transplantation in adults: Patient selection and pretransplantation evaluation"</a> and  <a class="medical medical_review" href="/d/html/1241.html" rel="external">"Model for End-stage Liver Disease (MELD)"</a>.)</p><p>Consultation with the surgeon in the immediate preoperative period is necessary to allow appropriate preparation for the specific surgical techniques planned for the anhepatic phase. Specifically, timing of transplant, donor quality and use of veno-venous bypass and/or continuous renal replacement therapy should be discussed. (See  <a class="medical medical_review" href="/d/html/94585.html" rel="external">"Liver transplantation: Anesthetic management", section on 'Specific surgical techniques'</a>.) </p><p>Notification of the transfusion medicine service or blood bank facilitates preparation for massive transfusion required during surgery. (See <a class="local">'Availability of blood products'</a> below.)</p><p class="headingAnchor" id="H794333072"><span class="h2">Liver pathophysiology: Anesthetic implications</span><span class="headingEndMark"> — </span>Marked pathophysiologic changes occur with liver failure that directly affect anesthetic management. These are evaluated and documented during pretransplantation medical evaluations and are noted during the preanesthetic consultation. (See  <a class="medical medical_review" href="/d/html/4585.html" rel="external">"Liver transplantation in adults: Patient selection and pretransplantation evaluation"</a>.)</p><p class="headingAnchor" id="H2027516116"><span class="h3">Hematologic changes</span></p><p class="headingAnchor" id="H3593790920"><span class="h4">Disorders of coagulation</span><span class="headingEndMark"> — </span>Conventional preoperative coagulation tests (eg, prothrombin time, international normalized ratio) will be available in the preoperative period. However, the overall effect of various coagulation abnormalities varies in individual patients with end-stage liver disease [<a href="#rid1">1-7</a>]. Thrombin generation may be normal, abnormal with coagulopathy and bleeding, or exaggerated with hypercoagulability and thrombotic complications [<a href="#rid3">3-6</a>]. These forms of "rebalanced" hemostasis are not reflected in standard clotting tests. Furthermore, standard tests may be insensitive to moderate reductions in clotting factor levels, do not assess hyperfibrinolysis, and neglect the contribution of platelets to clot formation [<a href="#rid1">1,2</a>]. (See  <a class="medical medical_review" href="/d/html/13932.html" rel="external">"Hemostatic abnormalities in patients with liver disease", section on 'Physiologic effects of hepatic dysfunction'</a>.)</p><p>Viscoelastic testing provides in vivo assessment of clot formation and is often employed before and during liver transplantation to assess coagulopathy as well as likely hypercoagulability. (See  <a class="medical medical_review" href="/d/html/94585.html" rel="external">"Liver transplantation: Anesthetic management", section on 'Blood and coagulation management'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Coagulopathy can be present due to reduction in all liver-derived procoagulant factors (eg, factors V, VII, IX, X, and XI, fibrinogen, thrombin), with compensatory increases of extrahepatic factors [<a href="#rid2">2,8</a>]. Also, thrombocytopenia is common due to both decreased hepatic production of thrombopoietin and splenic sequestration of platelets in patients with portal hypertension [<a href="#rid2">2,9</a>] (see <a class="local">'Cardiopulmonary changes'</a> below). Furthermore, hyperfibrinolysis typically occurs during the transplantation procedure due to increased fibrinolytic activity and decreased hepatic clearance of tissue plasminogen activator (tPA) [<a href="#rid10">10-13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypercoagulability with normal or exaggerated clot formation is present in some patients with end-stage liver disease, even those with thrombocytopenia. Anticoagulant factors (eg, antithrombin, protein S and protein C activity) and ADAMTS13 (a metalloprotease that cleaves high molecular weight von Willebrand factor [VWF]) are typically reduced in these patients, while VWF is elevated [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Splenomegaly (ie, an enlarged spleen that is congested with blood) is common in patients with cirrhosis from nonalcoholic etiologies. (See  <a class="medical medical_review" href="/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Splenomegaly'</a>.)</p><p></p><p class="headingAnchor" id="H616486176"><span class="h4">Anemia</span><span class="headingEndMark"> — </span>Anemia is often present, and its severity is noted, as this influences intraoperative decisions to transfuse salvaged or allogeneic blood during liver transplantation [<a href="#rid15">15</a>]. </p><p>Anemia in liver disease is multifactorial. Causes may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding (variceal or other)</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic inflammation</p><p class="bulletIndent1"><span class="glyph">●</span>Iron deficiency</p><p class="bulletIndent1"><span class="glyph">●</span>Splenic pooling of blood in patients with portal hypertension and splenomegaly</p><p class="bulletIndent1"><span class="glyph">●</span>Hemodilution from fluid retention</p><p class="bulletIndent1"><span class="glyph">●</span>Vitamin deficiencies (folate, vitamin B12)</p><p class="bulletIndent1"><span class="glyph">●</span>Bone marrow suppression from medications</p><p class="bulletIndent1"><span class="glyph">●</span>Bone marrow suppression from alcohol in some individuals</p><p class="bulletIndent1"><span class="glyph">●</span>Hemolysis</p><p></p><p>Mechanisms are discussed in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7150.html" rel="external">"Causes and diagnosis of iron deficiency and iron deficiency anemia in adults", section on 'Blood loss'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7149.html" rel="external">"Anemia of chronic disease/anemia of inflammation"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7151.html" rel="external">"Hematologic complications of alcohol use", section on 'Anemia'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7088.html" rel="external">"Burr cells, acanthocytes, and target cells: Disorders of red blood cell membrane", section on 'RBC changes in liver disease'</a>.)</p><p></p><p class="headingAnchor" id="H1929777042"><span class="h3">Cardiopulmonary changes</span><span class="headingEndMark"> — </span>The pretransplantation cardiopulmonary evaluation performed by the liver transplant team assesses presence and severity of pulmonary hypertension, hepatopulmonary syndrome, restrictive or obstructive lung disease, right ventricular (RV) or left ventricular (LV) cardiomyopathy, coronary artery disease, or valvular heart disease. (See  <a class="medical medical_review" href="/d/html/4585.html" rel="external">"Liver transplantation in adults: Patient selection and pretransplantation evaluation", section on 'Cardiopulmonary evaluation'</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vasodilation and high cardiac output </strong>– A vasodilatory hyperdynamic state with low systemic vascular resistance (SVR) is typically present in patients with liver failure [<a href="#rid16">16,17</a>]. Notably, these patients respond to intraoperative administration of vasopressor agents (eg, <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a>) in part because their endogenous arginine vasopressin levels may be inadequate [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1">Also, continuous low-level exposure to cytokines [<a href="#rid19">19</a>], as well as bacterial fragments [<a href="#rid20">20,21</a>], cause splanchnic hyperemia with pooling of blood in the splanchnic area. In addition, many patients have loss of intravascular volume due to ascites. Vasoconstrictors are activated via the sympathetic and renin-angiotensin-aldosterone systems as a compensatory mechanism to maintain blood pressure and organ perfusion by increasing intravascular volume, cardiac output (CO), and SVR in non-splanchnic organ beds [<a href="#rid22">22-24</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary hypertension</strong> – A chronically high CO may cause pulmonary hypertension that is initially reversible, but some patients develop irreversible pulmonary hypertension (PH) and RV dysfunction [<a href="#rid25">25</a>]. Portopulmonary hypertension is defined as the presence of PH associated with portal hypertension [<a href="#rid26">26</a>]. Severity of PH is evaluated with echocardiography or by right heart catheterization to estimate RV systolic pressure during the transplant team's preoperative workup (see  <a class="medical medical_review" href="/d/html/8266.html" rel="external">"Portopulmonary hypertension", section on 'Diagnostic evaluation'</a>). Evaluation includes determining whether increases in pulmonary artery pressure (PAP) are primarily due to high CO with volume overload (which may improve with diuresis) or due to intrinsically increased pulmonary vascular resistance (PVR), and whether PH improves with pulmonary vasodilators (typically, inhaled nitric oxide). The anesthesiologist and all members of the transplant team are consulted when a patient with moderate or severe PH (ie, mean PAP &gt;35 to 45 mmHg) is listed for liver transplantation. It is critically important to continue chronically administered medications throughout the perioperative period to ameliorate PH in such patients. Severe PH unresponsive to pulmonary vasodilators may preclude a patient from receiving a donor liver since perioperative mortality is high [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/d/html/4585.html" rel="external">"Liver transplantation in adults: Patient selection and pretransplantation evaluation", section on 'Cardiopulmonary evaluation'</a> and  <a class="medical medical_review" href="/d/html/94362.html" rel="external">"Anesthesia for noncardiac surgery in patients with pulmonary hypertension or right heart failure", section on 'Management of chronic medications'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hepatopulmonary syndrome – </strong>Hepatopulmonary syndrome is characterized by portal hypertension and abnormal arterial oxygenation caused by intrapulmonary vascular dilatations and shunting [<a href="#rid27">27</a>]. Pretransplantation evaluation includes identification and assessment of transpulmonary shunts with transthoracic contrast echocardiography and a "bubble study" to determine whether hepatopulmonary syndrome is the primary cause of hypoxemia. (See  <a class="medical medical_review" href="/d/html/8248.html" rel="external">"Hepatopulmonary syndrome in adults: Prevalence, causes, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">Intraoperative anesthetic management is not generally affected by mild-to-moderate symptoms of hepatopulmonary syndrome. Oxygenation typically improves when the patient is placed in the supine position or undergoes positive pressure ventilation. This occurs because increases in intrathoracic pressure cause compression of the intrapulmonary vasculature with decreases in abnormal transpulmonary shunting compared with the upright position and spontaneous ventilation [<a href="#rid28">28</a>]. However, severe hepatopulmonary syndrome may cause refractory hypoxia. (See  <a class="medical medical_review" href="/d/html/1625.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: Overview"</a> and  <a class="medical medical_review" href="/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Restrictive pulmonary defects –</strong> In some patients, marked ascites results in restrictive pulmonary defects. These may be exacerbated by pleural effusion (ie, hepatic hydrothorax) which is usually on the right side. Thoracentesis with drainage may be performed before transplantation for severe pleural effusion [<a href="#rid29">29,30</a>].</p><p></p><p class="headingAnchor" id="H3443406209"><span class="h3">Hepatorenal syndrome</span><span class="headingEndMark"> — </span>Some patients have hypoperfusion of the kidney resulting in renal insufficiency (ie, hepatorenal syndrome) due to the net effect of chronically low SVR, splanchnic hyperemia, and low intravascular volume (see <a class="local">'Cardiopulmonary changes'</a> above) [<a href="#rid17">17,31,32</a>]. Intraoperative exacerbation of renal insufficiency and acute kidney injury (AKI) can occur during liver transplantation [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/d/html/2308.html" rel="external">"Hepatorenal syndrome"</a>.)</p><p>The use of the MELD score as an allocation tool for liver transplantation gives high preference to patients with renal dysfunction and as a consequence the number of combined liver kidney transplants has steadily increased over the last 15 to 20 years [<a href="#rid34">34</a>]. Continuous renal replacement therapy (CRRT) has been used for selected patients, as noted below (see  <a class="medical medical_review" href="/d/html/2308.html" rel="external">"Hepatorenal syndrome", section on 'Kidney replacement therapy'</a> and <a class="local">'Use of continuous renal replacement therapy'</a> below).</p><p>Some patients are candidates for simultaneous liver-kidney transplant surgery, as discussed in a separate topic [<a href="#rid35">35,36</a>]. (See  <a class="medical medical_review" href="/d/html/7331.html" rel="external">"Kidney function and non-kidney solid organ transplantation", section on 'Approach in liver transplant candidates'</a>.)</p><p class="headingAnchor" id="H1434244314"><span class="h3">Esophageal pathology</span><span class="headingEndMark"> — </span>Transesophageal echocardiography (TEE) is often used during liver transplantation [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/d/html/94585.html" rel="external">"Liver transplantation: Anesthetic management", section on 'Monitoring considerations'</a>.)</p><p>The presence of previously diagnosed gastric and esophageal varices is noted during the preanesthetic consultation [<a href="#rid38">38</a>]. Primary prophylaxis for esophageal variceal bleeding often includes the use of beta blockers, which may predispose patients to intraoperative hypotension (see  <a class="medical medical_review" href="/d/html/1245.html" rel="external">"Primary prevention of bleeding from esophageal varices in patients with cirrhosis", section on 'Preventive strategies'</a>). However, upper gastrointestinal (UGI) hemorrhage and other complications of TEE monitoring are rare in patients with end-stage liver disease, even among those with coagulopathy, thrombocytopenia, or esophageal varices [<a href="#rid37">37,39-44</a>]. Extra care with probe lubrication and insertion are appropriate to minimize this risk [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Contraindications and precautions'</a>.) </p><p class="headingAnchor" id="H4269785381"><span class="h3">Obstructive sleep apnea</span><span class="headingEndMark"> — </span>Patients who require liver transplantation due to non-alcoholic steatohepatitis (NASH) are likely to have metabolic syndrome and obstructive sleep apnea [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/d/html/3625.html" rel="external">"Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults", section on 'Association with other disorders'</a>.)</p><p class="headingAnchor" id="H1146318254"><span class="h2">Planning for postoperative analgesia</span><span class="headingEndMark"> — </span>Chronic opioid use is relatively frequent in patients waiting for liver transplantation [<a href="#rid47">47</a>]. In one study, postoperative opioid requirements were significantly higher in patients with preoperative opioid prescriptions in the first 24 hours (206 ± 319 versus 60 ± 34 mg) and at 7 postoperative days (57 ± 71 versus 19 ± 15 mg) compared with patients not using preoperative opioids [<a href="#rid47">47</a>]. Also, the incidence of chronic postsurgical pain was higher in those with preoperative opioid use (71 versus 46 percent).</p><p>Multimodal pain therapy has been suggested to decrease postoperative opioid requirements after liver transplantation; however, it is unclear whether such therapy also reduces chronic postsurgical pain [<a href="#rid48">48,49</a>].</p><p class="headingAnchor" id="H3295389248"><span class="h2">Availability of blood products</span><span class="headingEndMark"> — </span>Typing and crossmatching for an adequate number of blood products (eg, 10 units of red blood cells [RBCs], 10 units of fresh frozen plasma [FFP], 6 units of platelets [one platelet pack]) should be accomplished in the preoperative period as soon as the recipient is identified and arrives at the transplant center, especially if the patient has received prior transfusions or has been pregnant and may have developed alloantibodies.</p><p class="headingAnchor" id="H1275213662"><span class="h1">TIMING FOR ANESTHETIC INDUCTION</span></p><p class="headingAnchor" id="H2518883748"><span class="h2">Communication and coordination</span><span class="headingEndMark"> — </span>Donor liver procurement (either cadaveric or living donor) is carefully coordinated to minimize the time from resection to implantation (ie, cold ischemic time). The recipient does not proceed to the operating room until the donor liver has been initially assessed to determine if its quality is adequate for transplantation. In some cases, timing of induction is influenced by whether the surgeon wants to visualize the graft or obtain a biopsy to ensure adequate graft quality prior to bringing the patient to the operating room. </p><p>During the preoperative period, regular communication between the anesthesiologist and the surgeon and/or transplant coordinator ensures optimal timing for induction of anesthesia. This is critically important because anesthetizing a patient with severe liver failure may precipitate deterioration of liver function and trigger acute-on-chronic liver failure from which the patient may not subsequently recover unless a high-quality donor liver has been implanted [<a href="#rid50">50</a>].</p><p>Cold preservation leads to liver injury over time. In general, cold ischemic times &gt;12 hours may impact donor organ viability and graft survival, but some poor-quality donor organs (eg, donation after cardiac death [DCD]) may not tolerate cold ischemic times &gt;6 to 10 hours. (See  <a class="medical medical_review" href="/d/html/4592.html" rel="external">"Liver transplantation in adults: Deceased donor evaluation and selection", section on 'Cold ischemia time'</a> and  <a class="medical medical_review" href="/d/html/4592.html" rel="external">"Liver transplantation in adults: Deceased donor evaluation and selection", section on 'Donation after circulatory death'</a>.)</p><p class="headingAnchor" id="H874121492"><span class="h2">Final checking of blood products</span><span class="headingEndMark"> — </span>All blood products should be available at the time of the incision. (See <a class="local">'Availability of blood products'</a> above.)</p><p class="headingAnchor" id="H2423511224"><span class="h2">Preoperative fasting status</span><span class="headingEndMark"> — </span>Since liver transplant recipients receive notification of a potential matched donor liver within hours of receiving the organ, preoperative fasting may be inadequate to allow for stomach emptying. </p><p>A transplant is not elective and cannot be postponed. If there is inadequate time to adhere to fasting guidelines, or if the patient has moderate to severe ascites, rapid sequence induction of anesthesia is performed  (<a class="graphic graphic_table graphicRef94641" href="/d/graphic/94641.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/94585.html" rel="external">"Liver transplantation: Anesthetic management", section on 'Induction of general anesthesia'</a> and  <a class="medical medical_review" href="/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia"</a>.) </p><p class="headingAnchor" id="H4190692943"><span class="h1">SPECIAL SITUATIONS</span></p><p class="headingAnchor" id="H1514645174"><span class="h2">Considerations for patient testing positive for the COVID-19</span><span class="headingEndMark"> — </span>For patients who contract COVID-19 while waitlisted for liver transplantation, a reasonable approach is to become inactive on the waitlist until they become asymptomatic and one (or two for higher sensitivity) COVID-19 nucleic acid amplification test (NAAT) has been negative. (See  <a class="medical medical_review" href="/d/html/127582.html" rel="external">"COVID-19: Issues related to solid organ transplantation"</a>.)</p><p class="headingAnchor" id="H3514625805"><span class="h2">Acute liver failure with increased intracranial pressure</span><span class="headingEndMark"> — </span>Patients with acute liver failure and increased intracranial pressure (ICP) are at high risk for complications and poor outcome. In one study of such patients undergoing liver transplantation, 11.3 percent suffered death by neurologic criteria (“brain death”) during or shortly after surgery [<a href="#rid51">51,52</a>].</p><p>The American Association for the Study of Liver Diseases (AASLD) recommends a target cerebral perfusion pressure (CPP) of 60 to 70 mmHg, where CPP = mean arterial pressure (MAP) – ICP [<a href="#rid53">53</a>]. Any therapies for elevated ICP that were initiated in the preoperative period should be continued throughout the perioperative period. If an ICP monitor is in place, monitoring is continued throughout the perioperative period to allow rapid identification and intervention for increases in ICP (eg, hyperventilation and/or administration of hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>) [<a href="#rid54">54,55</a>]. Other therapies may include administration of <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> and/or hypertonic saline (eg, 2.7 to 3 percent solution) to achieve a blood sodium concentration of approximately 145 to 150 mEq/L. Some patients with acute liver failure and increased ICP undergo moderate cooling (32 to 33<sup>o </sup>C) in the preoperative period although effects on outcome are unclear [<a href="#rid56">56-58</a>]. If initiated in the preoperative period, moderate hypothermia should continue throughout the intraoperative period (and possibly postoperatively) to avoid rebound increases in ICP, even if coagulopathy is present. In selected patients, veno-venous (VV) bypass may be employed to avoid hemodynamic instability that may cause marked changes in CPP [<a href="#rid59">59</a>]. Furthermore, factors that may exacerbate neurologic injury (eg, hyperthermia, hyperglycemia) are carefully avoided. (See  <a class="medical medical_review" href="/d/html/3570.html" rel="external">"Acute liver failure in adults: Management and prognosis", section on 'Intracranial pressure monitoring'</a> and  <a class="medical medical_review" href="/d/html/3570.html" rel="external">"Acute liver failure in adults: Management and prognosis", section on 'Induction of hypothermia'</a>.)</p><p class="headingAnchor" id="H3592567914"><span class="h2">Use of continuous renal replacement therapy</span><span class="headingEndMark"> — </span>Chronic kidney disease is common in patients with liver disease. Recipient selection criteria for donor livers give strong preference to patients with severely impaired kidney function or kidney failure. Such patients may need either intermittent or continuous renal replacement therapy (CRRT) prior to transplantation. </p><p>Also, patients with severe kidney dysfunction who are not yet on dialysis may benefit from intraoperative CRRT. However, the volume of fluid removed is only approximately 300 mL/h, potassium clearance is inefficient and depends on effluent rate (dose), and lactate clearance is low during intraoperative CRRT because the technique corrects acidosis primarily by including bicarbonate in the dialysate [<a href="#rid60">60-62</a>]<em>.</em> In addition, sodium levels must be closely observed to avoid overly rapid correction in patients with severe hyponatremia [<a href="#rid62">62</a>]. (See  <a class="medical medical_review" href="/d/html/7331.html" rel="external">"Kidney function and non-kidney solid organ transplantation", section on 'Approach in liver transplant candidates'</a> and  <a class="medical medical_review" href="/d/html/2308.html" rel="external">"Hepatorenal syndrome", section on 'Kidney replacement therapy'</a>.)</p><p>CRRT is used in at least 35 percent of liver transplant centers in the United States [<a href="#rid43">43,63</a>]. Adequate dialysis access sites should be established before surgery commences if CRRT is planned. </p><p class="headingAnchor" id="H1652476933"><span class="h2">Living donor transplantation</span><span class="headingEndMark"> — </span>Anesthetic and surgical management for partial hepatic resection in a living liver donor and techniques for left or right liver lobe transplantation into the recipient are discussed separately. (See  <a class="medical medical_review" href="/d/html/91242.html" rel="external">"Anesthesia for the patient with liver disease", section on 'Anesthesia for hepatic resection'</a> and  <a class="medical medical_review" href="/d/html/4590.html" rel="external">"Living donor liver transplantation in adults"</a>.)</p><p class="headingAnchor" id="H794953100"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/113977.html" rel="external">"Society guideline links: Liver transplantation"</a>.)</p><p class="headingAnchor" id="H3958041957"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preanesthetic consultation</strong> – Includes assessment of pathophysiologic changes that occur with progressive liver failure and may directly affect anesthetic management:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hematologic</strong> – Coagulopathy with bleeding or hypercoagulability with thrombosis (or both) may be present, as well as anemia and splenomegaly. (See <a class="local">'Hematologic changes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiopulmonary</strong> - Considerations include (see <a class="local">'Cardiopulmonary changes'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Cardiovascular changes produce a vasodilatory hyperdynamic state with likely requirements for intraoperative administration of vasoconstrictors such as <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a>. (See <a class="local">'Cardiopulmonary changes'</a> above and  <a class="medical medical_review" href="/d/html/94585.html" rel="external">"Liver transplantation: Anesthetic management", section on 'Hemodynamic and vasopressor management'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Pulmonary hypertension (PH) with right ventricular dysfunction may be present. Severity and reversibility of pulmonary hypertension are noted, and chronically administered medications to ameliorate PH are continued throughout the perioperative period. (See <a class="local">'Cardiopulmonary changes'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with severe hepatopulmonary syndrome may have refractory hypoxia. Marked ascites results in restrictive pulmonary defects that are exacerbated by pleural effusion (ie, hepatic hydrothorax). Preoperative thoracentesis with drainage may be performed.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Kidney disease </strong>– Chronic kidney disease (eg, hepatorenal syndrome) may be present due to the net effect of decreased renal blood flow due to chronically low systemic vascular resistance, splanchnic hyperemia, and low intravascular volume status. Intraoperative continuous renal replacement therapy (CRRT) is used by some centers to remove excess fluid, correct acid-base abnormalities, treat hyperkalemia, and correct severe hyponatremia. Adequate dialysis access sites are established before surgery commences if intraoperative CRRT is planned. (See <a class="local">'Hepatorenal syndrome'</a> above and <a class="local">'Use of continuous renal replacement therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Increased ICP</strong> – For patients with acute liver failure and increased intracranial pressure (ICP), therapies initiated in the preoperative period (eg, <a class="drug drug_general" data-topicid="9587" href="/d/drug information/9587.html" rel="external">mannitol</a> and/or hypertonic <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>, hypothermia to 32 to 33°C) are continued during the perioperative period. If an ICP monitor is in place, monitoring is continued throughout the procedure to allow rapid identification and intervention for increases in ICP. (See <a class="local">'Acute liver failure with increased intracranial pressure'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Varices</strong> – Esophageal or gastric varices are noted. Although not a contraindication to intraoperative use of transesophageal echocardiography (TEE) during liver transplantation, extra care with probe lubrication and insertion are appropriate. (See <a class="local">'Esophageal pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing</strong>– Donor liver procurement is carefully coordinated to minimize time from resection to implantation (cold ischemic time).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Communication and coordination</strong> – Before transport of the patient to the operating room, preoperative communication with the surgeon and transfusion medicine service or blood bank is necessary to establish that the donor liver has been assessed and is of sufficient quality to be suitable for transplantation. (See <a class="local">'Timing for anesthetic induction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Availability of blood products</strong> – Typing and crossmatching for an adequate number of blood products (eg, 10 units of packed red blood cells [PRBCs], 10 units of fresh frozen plasma [FFP], 6 units of platelets [one platelet pack]) should be accomplished in the preoperative period. These products should be available in the operating room before surgical incision. (See <a class="local">'Availability of blood products'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fasting</strong> – Notification of a potential matched organ within hours of receiving the organ may not allow a preoperative fasting period adequate for stomach emptying  (<a class="graphic graphic_table graphicRef94641" href="/d/graphic/94641.html" rel="external">table 1</a>); thus, rapid sequence induction is frequently necessary. (See <a class="local">'Preoperative fasting status'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>COVID-19</strong> – For patients who contract COVID-19, a reasonable approach is to become inactive on the waitlist until they become asymptomatic and one (or two for higher sensitivity) COVID-19 nucleic acid amplification test (NAAT) has been negative. (See <a class="local">'Considerations for patient testing positive for the COVID-19'</a> above.)</p><p></p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Townsend JC, Heard R, Powers ER, Reuben A. Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization. Am J Cardiol 2012; 110:1062.</a></li><li><a class="nounderline abstract_t">Forkin KT, Colquhoun DA, Nemergut EC, Huffmyer JL. The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management. Anesth Analg 2018; 126:46.</a></li><li><a class="nounderline abstract_t">Markin NW, Ringenberg KJ, Kassel CA, et al. 2018 Clinical Update in Liver Transplantation. J Cardiothorac Vasc Anesth 2019; 33:3239.</a></li><li><a class="nounderline abstract_t">Fisher C, Patel VC, Stoy SH, et al. Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure. J Crit Care 2018; 43:54.</a></li><li><a class="nounderline abstract_t">Habib M, Roberts LN, Patel RK, et al. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int 2014; 34:672.</a></li><li><a class="nounderline abstract_t">Lisman T, Bakhtiari K, Pereboom IT, et al. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010; 52:355.</a></li><li><a class="nounderline abstract_t">Massicotte L, Beaulieu D, Thibeault L, et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 2008; 85:956.</a></li><li><a class="nounderline abstract_t">Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002; 22:83.</a></li><li><a class="nounderline abstract_t">Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med 2016; 8:39.</a></li><li><a class="nounderline abstract_t">Hu KQ, Yu AS, Tiyyagura L, et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 2001; 96:1581.</a></li><li><a class="nounderline abstract_t">Ferro D, Celestini A, Violi F. Hyperfibrinolysis in liver disease. Clin Liver Dis 2009; 13:21.</a></li><li><a class="nounderline abstract_t">Dzik WH, Arkin CF, Jenkins RL, Stump DC. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood 1988; 71:1090.</a></li><li><a class="nounderline abstract_t">Cheema SP, Webster NR, Dunn F, Bellamy MC. Mediators of fibrinolysis in orthotopic liver transplantation. Clin Transplant 1996; 10:24.</a></li><li><a class="nounderline abstract_t">Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44:53.</a></li><li><a class="nounderline abstract_t">Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol 2009; 15:4653.</a></li><li><a class="nounderline abstract_t">Martell M, Coll M, Ezkurdia N, et al. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 2010; 2:208.</a></li><li><a class="nounderline abstract_t">KOWALSKI HJ, ABELMANN WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953; 32:1025.</a></li><li><a class="nounderline abstract_t">Wagener G, Kovalevskaya G, Minhaz M, et al. Vasopressin deficiency and vasodilatory state in end-stage liver disease. J Cardiothorac Vasc Anesth 2011; 25:665.</a></li><li><a class="nounderline abstract_t">Poovorawan K, Tangkijvanich P, Chirathaworn C, et al. Circulating cytokines and histological liver damage in chronic hepatitis B infection. Hepat Res Treat 2013; 2013:757246.</a></li><li><a class="nounderline abstract_t">Szeto CC, Kwan BC, Chow KM, et al. Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients. PLoS One 2015; 10:e0125162.</a></li><li><a class="nounderline abstract_t">Alexopoulou A, Agiasotelli D, Vasilieva LE, Dourakis SP. Bacterial translocation markers in liver cirrhosis. Ann Gastroenterol 2017; 30:486.</a></li><li><a class="nounderline abstract_t">Simões E Silva AC, Miranda AS, Rocha NP, Teixeira AL. Renin angiotensin system in liver diseases: Friend or foe? World J Gastroenterol 2017; 23:3396.</a></li><li><a class="nounderline abstract_t">Arroyo V, Planas R, Gaya J, et al. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983; 13:271.</a></li><li><a class="nounderline abstract_t">Bichet DG, Van Putten VJ, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982; 307:1552.</a></li><li><a class="nounderline abstract_t">Budhiraja R, Hassoun PM. Portopulmonary hypertension: a tale of two circulations. Chest 2003; 123:562.</a></li><li><a class="nounderline abstract_t">McGlothlin DP, Granton J, Klepetko W, et al. ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. J Heart Lung Transplant 2022; 41:1135.</a></li><li><a class="nounderline abstract_t">Ho V. Current concepts in the management of hepatopulmonary syndrome. Vasc Health Risk Manag 2008; 4:1035.</a></li><li><a class="nounderline abstract_t">Fauconnet P, Klopfenstein CE, Schiffer E. Hepatopulmonary syndrome: the anaesthetic considerations. Eur J Anaesthesiol 2013; 30:721.</a></li><li><a class="nounderline abstract_t">Liu LU, Haddadin HA, Bodian CA, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004; 126:142.</a></li><li><a class="nounderline abstract_t">Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int 2009; 3:582.</a></li><li><a class="nounderline abstract_t">Newby DE, Hayes PC. Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'. QJM 2002; 95:827.</a></li><li><a class="nounderline abstract_t">Bolognesi M, Di Pascoli M, Verardo A, Gatta A. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol 2014; 20:2555.</a></li><li><a class="nounderline abstract_t">Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015; 64:531.</a></li><li><a class="nounderline abstract_t">Asch WS, Bia MJ. New Organ Allocation System for Combined Liver-Kidney Transplants and the Availability of Kidneys for Transplant to Patients with Stage 4-5 CKD. Clin J Am Soc Nephrol 2017; 12:848.</a></li><li><a class="nounderline abstract_t">Formica RN, Aeder M, Boyle G, et al. Simultaneous Liver-Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources. Am J Transplant 2016; 16:758.</a></li><li><a class="nounderline abstract_t">Miles CD, Westphal S, Liapakis A, Formica R. Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List. Curr Transplant Rep 2018; 5:1.</a></li><li><a class="nounderline abstract_t">De Marchi L, Wang CJ, Skubas NJ, et al. Safety and Benefit of Transesophageal Echocardiography in Liver Transplant Surgery: A Position Paper From the Society for the Advancement of Transplant Anesthesia (SATA). Liver Transpl 2020; 26:1019.</a></li><li><a class="nounderline abstract_t">Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg 2014; 118:21.</a></li><li><a class="nounderline abstract_t">Burger-Klepp U, Karatosic R, Thum M, et al. Transesophageal echocardiography during orthotopic liver transplantation in patients with esophagoastric varices. Transplantation 2012; 94:192.</a></li><li><a class="nounderline abstract_t">Myo Bui CC, Worapot A, Xia W, et al. Gastroesophageal and hemorrhagic complications associated with intraoperative transesophageal echocardiography in patients with model for end-stage liver disease score 25 or higher. J Cardiothorac Vasc Anesth 2015; 29:594.</a></li><li><a class="nounderline abstract_t">Pai SL, Aniskevich S 3rd, Feinglass NG, et al. Complications related to intraoperative transesophageal echocardiography in liver transplantation. Springerplus 2015; 4:480.</a></li><li><a class="nounderline abstract_t">Markin NW, Sharma A, Grant W, Shillcutt SK. The safety of transesophageal echocardiography in patients undergoing orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2015; 29:588.</a></li><li><a class="nounderline abstract_t">Schumann R, Mandell MS, Mercaldo N, et al. Anesthesia for liver transplantation in United States academic centers: intraoperative practice. J Clin Anesth 2013; 25:542.</a></li><li><a class="nounderline abstract_t">De Pietri L, Mocchegiani F, Leuzzi C, et al. Transoesophageal echocardiography during liver transplantation. World J Hepatol 2015; 7:2432.</a></li><li><a class="nounderline abstract_t">Porter TR, Shillcutt SK, Adams MS, et al. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2015; 28:40.</a></li><li><a class="nounderline abstract_t">Sharma S, Stine JG, Verbeek T, Bezinover D. Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist. J Cardiothorac Vasc Anesth 2022; 36:2616.</a></li><li><a class="nounderline abstract_t">Fukazawa K, Rodriguez PJ, Fong CT, Gologorsky E. Perioperative Opioid Use and Chronic Post-Surgical Pain after Liver Transplantation: A Single Center Observational Study. J Cardiothorac Vasc Anesth 2020; 34:1815.</a></li><li><a class="nounderline abstract_t">Kutzler HL, Gannon R, Nolan W, et al. Opioid Avoidance in Liver Transplant Recipients: Reduction in Postoperative Opioid Use Through a Multidisciplinary Multimodal Approach. Liver Transpl 2020; 26:1254.</a></li><li><a class="nounderline abstract_t">Tong K, Nolan W, O'Sullivan DM, et al. Implementation of a Multimodal Pain Management Order Set Reduces Perioperative Opioid Use after Liver Transplantation. Pharmacotherapy 2019; 39:975.</a></li><li><a class="nounderline abstract_t">Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999; 29:1617.</a></li><li><a class="nounderline abstract_t">Kumar SS, Mashour GA, Picton P. Neurologic Considerations and Complications Related to Liver Transplantation. Anesthesiology 2018; 128:1008.</a></li><li><a class="nounderline abstract_t">Vaquero J, Fontana RJ, Larson AM, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11:1581.</a></li><li><a class="nounderline abstract_t">Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012; 55:965.</a></li><li><a class="nounderline abstract_t">Keays R, Potter D, O'Grady J, et al. Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure. Q J Med 1991; 79:425.</a></li><li><a class="nounderline abstract_t">Detry O, Arkadopoulos N, Ting P, et al. Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation 1999; 67:767.</a></li><li><a class="nounderline abstract_t">Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 2004; 127:1338.</a></li><li><a class="nounderline abstract_t">Jalan R, O Damink SW, Deutz NE, et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999; 354:1164.</a></li><li><a class="nounderline abstract_t">Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 2003; 75:2034.</a></li><li><a class="nounderline abstract_t">Prager MC, Washington DE, Lidofsky SD, et al. Intracranial pressure monitoring during liver transplant without venovenous bypass for fulminant hepatic failure. Transplant Proc 1993; 25:1841.</a></li><li><a class="nounderline abstract_t">Baek SD, Jang M, Kim W, et al. Benefits of Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation in Patients With Renal Dysfunction. Transplant Proc 2017; 49:1344.</a></li><li><a class="nounderline abstract_t">Adelmann D, Olmos A, Liu LL, et al. Intraoperative Management of Liver Transplant Patients Without the Routine Use of Renal Replacement Therapy. Transplantation 2018; 102:e229.</a></li><li><a class="nounderline abstract_t">Matuszkiewicz-Rowińska J, Wieliczko M, Małyszko J. Renal replacement therapy before, during, and after orthotopic liver transplantation. Ann Transplant 2013; 18:248.</a></li><li><a class="nounderline abstract_t">Nadim MK, Annanthapanyasut W, Matsuoka L, et al. Intraoperative hemodialysis during liver transplantation: a decade of experience. Liver Transpl 2014; 20:756.</a></li></ol></div><div id="topicVersionRevision">Topic 131317 Version 10.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22728001" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28795966" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30853406" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : 2018 Clinical Update in Liver Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28843665" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24164805" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20132999" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18408574" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Coagulation defects do not predict blood product requirements during liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11928081" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Coagulation disorders in liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27186144" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The pathophysiology of thrombocytopenia in chronic liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11374703" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19150306" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hyperfibrinolysis in liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3128347" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8652893" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mediators of fibrinolysis in orthotopic liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16799972" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19787828" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Spectrum of anemia associated with chronic liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21160999" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Physiopathology of splanchnic vasodilation in portal hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13096569" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The cardiac output at rest in Laennec's cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21126886" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Vasopressin deficiency and vasodilatory state in end-stage liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24288603" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Circulating cytokines and histological liver damage in chronic hepatitis B infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26010741" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28845103" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Bacterial translocation markers in liver cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28596676" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Renin angiotensin system in liver diseases: Friend or foe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6409652" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6755251" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12576381" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Portopulmonary hypertension: a tale of two circulations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36123001" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19183751" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Current concepts in the management of hepatopulmonary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24161936" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Hepatopulmonary syndrome: the anaesthetic considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15249455" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Outcome analysis of cirrhotic patients undergoing chest tube placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19669710" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Outcomes of patients with chest tube insertion for hepatic hydrothorax.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12454326" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24627591" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25631669" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28028050" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : New Organ Allocation System for Combined Liver-Kidney Transplants and the Availability of Kidneys for Transplant to Patients with Stage 4-5 CKD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26603142" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Simultaneous Liver-Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29564203" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32427417" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Safety and Benefit of Transesophageal Echocardiography in Liver Transplant Surgery: A Position Paper From the Society for the Advancement of Transplant Anesthesia (SATA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24356157" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22728290" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Transesophageal echocardiography during orthotopic liver transplantation in patients with esophagoastric varices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25661642" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Gastroesophageal and hemorrhagic complications associated with intraoperative transesophageal echocardiography in patients with model for end-stage liver disease score 25 or higher.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26361581" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Complications related to intraoperative transesophageal echocardiography in liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25622974" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The safety of transesophageal echocardiography in patients undergoing orthotopic liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23994704" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Anesthesia for liver transplantation in United States academic centers: intraoperative practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26483865" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Transoesophageal echocardiography during liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25559474" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34391652" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31952905" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Perioperative Opioid Use and Chronic Post-Surgical Pain after Liver Transplantation: A Single Center Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32657478" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Opioid Avoidance in Liver Transplant Recipients: Reduction in Postoperative Opioid Use Through a Multidisciplinary Multimodal Approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31446626" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Implementation of a Multimodal Pain Management Order Set Reduces Perioperative Opioid Use after Liver Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10347099" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The risk of surgery in patients with liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29498949" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Neurologic Considerations and Complications Related to Liver Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16315300" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22213561" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1924677" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10096539" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Intracranial pressure during liver transplantation for fulminant hepatic failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15521003" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10513710" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12829907" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8470193" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Intracranial pressure monitoring during liver transplant without venovenous bypass for fulminant hepatic failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28736005" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Benefits of Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation in Patients With Renal Dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29470352" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Intraoperative Management of Liver Transplant Patients Without the Routine Use of Renal Replacement Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23792528" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Renal replacement therapy before, during, and after orthotopic liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24634344" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Intraoperative hemodialysis during liver transplantation: a decade of experience.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
